LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 6 of 15: Mean cell count and mean growth rate across biological replicate 3. - Dataset (ID:20242)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Relative Growth Rate After Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|
MCF7 | GW843682X | 0.04 | uM | LJP6 | 72 | hr | 1209 | 2523 | 4093 | 0.6166 | 0.4557 |
MCF7 | HG-5-113-01 | 0.04 | uM | LJP5 | 72 | hr | 1209 | 3957 | 4093 | 0.9668 | 0.9528 |
MCF7 | HG-5-88-01 | 0.04 | uM | LJP6 | 72 | hr | 1209 | 3074 | 4093 | 0.7510 | 0.6466 |
MCF7 | Imatinib | 0.04 | uM | LJP6 | 72 | hr | 1209 | 3887 | 4093 | 0.9498 | 0.9288 |
MCF7 | JNK-9L | 0.04 | uM | LJP6 | 72 | hr | 1209 | 3341 | 4093 | 0.8164 | 0.7394 |
MCF7 | JW-7-24-1 | 0.04 | uM | LJP6 | 72 | hr | 1209 | 2904 | 4093 | 0.7097 | 0.5879 |
MCF7 | Lapatinib | 0.04 | uM | LJP6 | 72 | hr | 1209 | 3516 | 4093 | 0.8591 | 0.8000 |
MCF7 | LDN-193189 | 0.04 | uM | LJP5 | 72 | hr | 1209 | 4394 | 4093 | 1.0737 | 1.1046 |
MCF7 | Linifanib | 0.04 | uM | LJP6 | 72 | hr | 1209 | 4004 | 4093 | 0.9784 | 0.9694 |
MCF7 | Linsitinib | 0.04 | uM | LJP5 | 72 | hr | 1209 | 3271 | 4093 | 0.7992 | 0.7149 |
MCF7 | Mitoxantrone | 0.04 | uM | LJP5 | 72 | hr | 1209 | 1239 | 4093 | 0.3029 | 0.0104 |
MCF7 | Mitoxantrone | 0.04 | uM | LJP6 | 72 | hr | 1209 | 1258 | 4093 | 0.3074 | 0.0168 |
MCF7 | MK2206 | 0.04 | uM | LJP6 | 72 | hr | 1209 | 2425 | 4093 | 0.5925 | 0.4215 |
MCF7 | Neratinib | 0.04 | uM | LJP5 | 72 | hr | 1209 | 3690 | 4093 | 0.9017 | 0.8605 |
MCF7 | Nilotinib | 0.04 | uM | LJP5 | 72 | hr | 1209 | 4224 | 4093 | 1.0321 | 1.0455 |
MCF7 | Nintedanib | 0.04 | uM | LJP6 | 72 | hr | 1209 | 4173 | 4093 | 1.0197 | 1.0280 |
MCF7 | NU7441 | 0.04 | uM | LJP5 | 72 | hr | 1209 | 4014 | 4093 | 0.9807 | 0.9726 |
MCF7 | Dactolisib | 0.04 | uM | LJP5 | 72 | hr | 1209 | 1186 | 4093 | 0.2899 | -0.0079 |
MCF7 | NVP-TAE684 | 0.04 | uM | LJP6 | 72 | hr | 1209 | 1984 | 4093 | 0.4848 | 0.2687 |
MCF7 | Palbociclib | 0.04 | uM | LJP6 | 72 | hr | 1209 | 2761 | 4093 | 0.6746 | 0.5381 |
MCF7 | PD0325901 | 0.04 | uM | LJP5 | 72 | hr | 1209 | 2624 | 4093 | 0.6412 | 0.4907 |
MCF7 | PD0325901 | 0.04 | uM | LJP6 | 72 | hr | 1209 | 2638 | 4093 | 0.6446 | 0.4955 |
MCF7 | PD173074 | 0.04 | uM | LJP6 | 72 | hr | 1209 | 4081 | 4093 | 0.9972 | 0.9961 |
MCF7 | PD184352 | 0.04 | uM | LJP5 | 72 | hr | 1209 | 3272 | 4093 | 0.7996 | 0.7155 |
MCF7 | Pelitinib | 0.04 | uM | LJP5 | 72 | hr | 1209 | 4399 | 4093 | 1.0748 | 1.1061 |